Newbridge Financial Services Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1K | Buy |
654
+1
| +0.2% | +$38 | ﹤0.01% | 659 |
|
|
2025
Q1 | $25.3K | Buy |
653
+444
| +212% | +$17.2K | 0.01% | 498 |
|
|
2024
Q4 | $7.07K | Sell |
209
-564
| -73% | -$19.1K | ﹤0.01% | 804 |
|
|
2024
Q3 | $31.6K | Sell |
773
-2,330
| -75% | -$95.3K | 0.01% | 312 |
|
|
2024
Q2 | $119K | Buy |
3,103
+1,963
| +172% | +$75.6K | 0.04% | 243 |
|
|
2024
Q1 | $48.9K | Buy |
+1,140
| New | +$48.9K | 0.02% | 399 |
|
|
2023
Q1 | – | Sell |
-339
| Closed | -$11.9K | – | 1443 |
|
|
2022
Q4 | $11.9K | Buy |
339
+320
| +1,684% | +$11.2K | 0.01% | 874 |
|
|
2022
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 1297 |
|
|
2022
Q2 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 1273 |
|